总时间（秒）：16.49
问答时间（秒）：16.24

```json
[
  {
    "variant_string_id": "EGFR L858R",
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper defines EGFR mutations (like L858R) as drivers of lung cancer through constitutive activation of the tyrosine kinase domain, leading to uncontrolled cell proliferation.",
        "judgment": "Yes",
        "reasoning": "The paper explicitly states the mechanism of EGFR mutations in lung cancer and their effect on cell proliferation.",
        "next_step_or_outcome": "Proceed to Step 3"
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays.",
        "extracted_paper_info": "Kinase activity assays were performed to assess the effect of the L858R mutation on EGFR kinase activity.",
        "judgment": "Yes",
        "reasoning": "The assay (kinase activity) is applicable as EGFR mutation's pathogenetic role is linked to kinase activity.",
        "next_step_or_outcome": "Proceed to Step 2"
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "Kinase activity assays are commonly used in the field to evaluate the effect of mutations on the tyrosine kinase domain.",
        "judgment": "Yes",
        "reasoning": "Kinase activity assays align with the defined disease mechanism by directly assessing the kinase activity affected by the mutation.",
        "next_step_or_outcome": "Proceed to Step 1"
      },
      {
        "step_name": "Sub-step 3a: Basic Controls and Replicates.",
        "extracted_paper_info": "Wild-type EGFR kinase activity was measured as a control. Multiple replicates (n=3) were used for each experiment.",
        "judgment": "Yes",
        "reasoning": "Both wild-type (normal) and potentially null/abnormal controls (not explicitly stated as being tested as part of a comparison), with replicates used.  Given that the L858R mutation’s effect is assessed *relative* to wildtype, the wildtype serves a useful comparative function.",
        "next_step_or_outcome": "Proceed to Sub-step 3c"
      },
      {
        "step_name": "Sub-step 3c: Variant Controls",
        "extracted_paper_info": "The paper mentions that kinase activity assays were compared to published data for other known pathogenic EGFR mutations (e.g., deletion mutations in exon 19).",
        "judgment": "Yes",
        "reasoning": "Comparison to previously established pathogenic variants acts as a variant control.",
        "next_step_or_outcome": "Proceed to Step 4"
      }
    ],
    "final_evidence_strength": {
      "type": "Pathogenic",
      "strength": "PS3_moderate"
    },
    "overall_conclusion": "The enhanced kinase activity observed with the L858R mutation, relative to wild-type and compared to known pathogenic variants, confirms its impact on the disease mechanism and supports a pathogenic role. While a direct OddsPath value wasn’t stated, the comparisons used to establish the assay's findings permit a classification of PS3_moderate."
  }
]
```